The following is a guest blog post by Sophie Beauvais of The Global Health Delivery Project at Harvard University. Her post discusses the virtual panel discussion they are hosting this week on second-line anti-TB drug management with Dr. Lucica Ditiu from the Stop TB Partnership and several World Health Organization (WHO) experts. In the fight […]
In this third post in a series of conversations with officials at the U.S. Centers for Disease Control and Prevention (CDC) discussing the CDC’s role in global HIV and tuberculosis research and development, Science Speaks sat down with John Vertefeuille, PhD – the country director for CDC in Haiti. There he leads a team of 55 and […]
HIV
As the federal Ending the HIV epidemic takes form, experts talk details, challenges: “How do we get there from here?” WASHINGTON, DC – Nearly four decades […]
Tuberculosis
But with a $3.3 billion shortfall in funding, gaps in treatment and prevention among the most vulnerable still take 4,000 lives a day For the first […]
Research & Development
While a World Health Organization-led strategy aims to provide 1.4 billion doses of vaccine against yellow fever to achieve 80% vaccination coverage across countries by 2026 […]
Policy
The following is a guest post by Jay Gribble of Health Policy Plus and Alyson Lipsky of RTI and Health Policy Plus Donors, implementers, and governments […]